CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Treasury Stock	Accumulated Other Comprehensive Income	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2020		93,379,508
Beginning balance at Dec. 31, 2020	$ 127,871	$ 9	$ 179,549		$ 93	$ (51,780)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	1,593		1,593
Unrealized gain on interest rate caplets	0
Unrealized gain on investment in convertible notes	469				469
Net income	1,501					1,501
Ending balance (in shares) at Mar. 31, 2021		93,379,508
Ending balance at Mar. 31, 2021	131,434	$ 9	181,142		562	(50,279)
Beginning balance (in shares) at Dec. 31, 2021		93,410,563		(701,305)
Beginning balance at Dec. 31, 2021	$ 158,461	$ 9	187,656	$ (8,983)	0	(20,221)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchase of common stock (in shares)	(1,087,990)	(1,087,990)		(1,087,990)
Repurchase of common stock	$ (13,934)			$ (13,934)
Stock-based compensation	1,605		1,605
Exercise of stock-based awards (in shares)		161,969
Exercise of stock-based awards	38		38
Unrealized gain on interest rate caplets	4,864				4,864
Unrealized gain on investment in convertible notes	0
Net income	15,788					15,788
Ending balance (in shares) at Mar. 31, 2022		92,484,542		(1,789,295)
Ending balance at Mar. 31, 2022	$ 166,822	$ 9	$ 189,299	$ (22,917)	$ 4,864	$ (4,433)